Replies to post #374576 on Anavex Life Sciences Corp (AVXL)

[raja48185]

Once the PHASE III DATA shows overwhelming efficacy for A 2-73 in ALZHEIMER’S, there is no denial of that!

Agree!

FDA will have to live with what the trials produce. The FDA will not ask for additional data when the data is conclusively showing efficacy!!

Hope so, but we are dealing with the FDA. We will know how they react should it happen.


Data speaks in ABSOLUTE terms

Agree!
Any hint of a weak signal, and you can bet a 50% haircut.